← All indications
Keratoconjunctivitis
Simultaneous inflammation of the cornea and conjunctiva.
Subtype terms (2)
More specific conditions that are subtypes of Keratoconjunctivitis in the MeSH hierarchy.
- Keratoconjunctivitis, Infectious
- Keratoconjunctivitis Sicca
29 drugs (17 approved, 12 experimental)
Drugs by status
Approved for this indication (6)
Phase 3 trials (1)
Phase 2 trials (1)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (23)
- Shire
- Bausch & Lomb
- Novartis
- Allergan
- Laboratoires Thea
- Ocusoft, Inc.
- ORA, Inc.
- Lifelong Vision Foundation
- The Eye Center and The Eye Foundation for Research in Ophthalmology
- Mahidol University
- Ophthalmic Consultants of Long Island
- Siriraj Hospital
- University of Padova
- University of the Philippines
- Virginia Eye Consultants
- Sun Yat-Sen University
- Eye Surgeons of Indiana
- Brar-Parekh Eye Associates
- Chicago Cornea Consultants, LTD
- University of Alabama, Birmingham
- Government of Belgium
- Ghent University
- Military Hospital of Tunis
Organization Involved with Phase 3 Indications (24)
- Astellas
- Merck
- Aurinia Pharmaceuticals Inc.
- C.T. Development America, Inc.
- Can-Fite BioPharma
- Santen Inc.
- Kala Pharmaceuticals, Inc.
- Mimetogen Pharmaceuticals USA, Inc.
- Ocular Technologies SARL
- Sponsor GmbH
- Otsuka
- National Eye Institute (NEI)
- University of Roma La Sapienza
- Campus Bio-Medico University
- Pontificia Universidad Catolica de Chile
- University of Louisville
- Instituto Universitario de Oftalmobiología Aplicada
- Icahn School of Medicine at Mount Sinai
- Auven Therapeutics
- Hebrew University
- SARcode Bioscience
- University of Texas at Houston
- University of Genoa
- Hospital Dr. Sótero del Río
Organization Involved with Phase 2 Indications (27)
- Regeneron
- Acucela Inc.
- Adenovir Pharma AB
- Pfizer
- Akari Therapeutics
- Dhp Korea Co., Ltd.
- Mitotech, SA
- Rigel Pharmaceuticals
- Price Vision Group
- University of London
- St. Erik Eye Hospital
- Tel Aviv University
- University of Copenhagen
- University of Ulsan
- Vanderbilt University
- Andover Eye Associates
- Sall Research Medical Center
- Total Eye Care, PA
- Martel Eye Medical Group
- Eye Center of Southern CT, P.C.
- Whitsett Vision Group
- Ecomprehensive Eye Care, Ltd
- Abrams Eye Center, Cleveland, OH
- South Shore Eye Care
- TFS Trial Form Support
- Statistics & Data Corporation
- Al-Farabi Kazakh National University
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (13)